Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
20-19 Tan BB06oz CAR T
- Development stage
- Unknown
- Lead developer
- Roswell Park Comprehensive Cancer Center
- Modality
- CAR-T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies, Gene Therapies
- Administration
- Intravenous
01
Overview
20-19 Tan BB06oz CAR T is an autologous, bispecific chimeric antigen receptor (CAR) T-cell therapy developed by Roswell Park Cancer Institute. It is designed to simultaneously target two B-cell antigens, CD19 and CD20, to reduce the risk of antigen escape, a common cause of relapse in single-target CAR-T therapies. The CAR construct is unique in its incorporation of tandem (Tan) signaling domains, specifically utilizing both a 4-1BB costimulatory domain and a mutated CD28 costimulatory domain to enhance T-cell persistence and potency. It is currently being evaluated in Phase I clinical trials for patients with relapsed or refractory CD19+ aggressive hematologic malignancies, including various types of B-cell lymphoma.
- Other names
- CD19/CD20 bispecific CAR-T cells with 4-1BB and mutated CD28 costimulatory domains
02
Targets
Beyond the preview
Go deeper on 20-19 Tan BB06oz CAR T.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 20-19 Tan BB06oz CAR T.